申请人:Dyckman Alaric
公开号:US20090105243A1
公开(公告)日:2009-04-23
Compounds having the formula (I),
and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, X and Z are as described in the specification.